What is XAGE's gross margin?

Longevity (XAGE) has a gross margin of 50% and a net margin of -476%.

What is XAGE's P/E ratio?

Track Longevity (XAGE) P/E ratio, ROE, and valuation metrics over time.

Where can I see XAGE's full financials?

See Longevity (XAGE) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Longevity (XAGE) Financials — Revenue, Earnings, Cash Flow

Also trades as: XAGEW (NASDAQ) · $vol 0M

$0.12

-0.01 (-10.12%)

Weekly Expected Move ±9.7%

$0 $0 $0 $0 $0

OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 35 · $176556 mcap · 893389 float · 0.151% daily turnover · Short 30% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$2M

Revenue

+60.3% YoY

$-7M

Net Income

+5.0% YoY

$-2M

Free Cash Flow

+34.5% YoY

50.4%

Gross Margin

-192.7%

Op. Margin

-475.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE109.8%

ROA-286.0%

ROIC56.6%

Valuation

P/E-0.0

P/B-0.0

EV/EBITDA-0.2

Leverage

Debt/Equity-0.04

Current Ratio0.07

Interest Cov.-353.8x

Quality Scores

Piotroski F3/9

Altman Z-131.39

Beneish M-22.94